IlluminOss Medical has developed a platform, disruptive technology for the orthopedic trauma market. It has achieved CE Mark approval in Europe, and has filed for expanded indications. IlluminOss has also completed its US pivotal clinical trial and is pursuing FDA approval via a De Novo 510(k) that is currently under review. The technology centers around image guided, minimally invasive conforming orthopedic implants that leverage its proprietary bone stabilization technology, the “IlluminOss System”. Through the unique and proprietary combination of balloons, light activated monomers and flexible catheters, IlluminOss has created the world’s first patient conforming intramedullary implant. The IlluminOss System has been safely and effectively used internationally since 2010 for a wide variety of clinical indications.
IlluminOss is recruiting U.S distributors to represent the product once FDA approval is granted.
The IlluminOss System
watch video »